Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

July 2026 | 51 pages | ID: I44E9351F69EN
MarketLine

Abstracts

Summary

Ionis Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Ionis Pharmaceuticals, Inc. (Ionis) is involved in discovering and developing ribonucleic acid (RNA)-targeted therapeutics. The company's major products include TRYNGOLZA, WAINUA, SPINRAZA, QALSODY, TEGSEDI, and WAYLIVRA, which are used to treat conditions such as familial chylomicronemia syndrome, hereditary transthyretin-mediated amyloidosis, spinal muscular atrophy, and amyotrophic lateral sclerosis. It develops products based on its proprietary antisense technology. Ionis collaborates with channel partners such as AstraZeneca and Biogen for the development and commercialization of its products. It also includes a series of products that are currently in various phases of clinical trials. The company operates in various geographic locations, targeting markets in the US, Europe, and other regions. The company is headquartered in Carlsbad, California, the US

Scope

• Detailed information on Ionis Pharmaceuticals, Inc. required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Ionis Pharmaceuticals, Inc. in the form of a SWOT analysis
• An in-depth view of the business model of Ionis Pharmaceuticals, Inc. including a breakdown and examination of key business segments
• Intelligence on Ionis Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Ionis Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

• Gain understanding of Ionis Pharmaceuticals, Inc. and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Ionis Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Ionis Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Contents

Company Snapshot
Ionis Pharmaceuticals, Inc.: Company Overview
Ionis Pharmaceuticals, Inc.: Overview and Key Facts
Ionis Pharmaceuticals, Inc.: Overview
Ionis Pharmaceuticals, Inc.: Key Facts
Ionis Pharmaceuticals, Inc.: Key Employees
Ionis Pharmaceuticals, Inc.: Key Employee Biographies
Ionis Pharmaceuticals, Inc.: Major Products and Services
Ionis Pharmaceuticals, Inc.: Management Statement
Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Ionis Pharmaceuticals, Inc.: Key Competitors
Ionis Pharmaceuticals, Inc.: Company Analysis
Ionis Pharmaceuticals, Inc.: Business Description
Ionis Pharmaceuticals, Inc.: SWOT Analysis
Ionis Pharmaceuticals, Inc.: SWOT Overview
Ionis Pharmaceuticals, Inc.: Strengths
Ionis Pharmaceuticals, Inc.: Weaknesses
Ionis Pharmaceuticals, Inc.: Opportunities
Ionis Pharmaceuticals, Inc.: Threats
Ionis Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Ionis Pharmaceuticals, Inc.: Financial Deals Overview
Ionis Pharmaceuticals, Inc.: Targets and Partners
Ionis Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD*
Ionis Pharmaceuticals, Inc.: Advisors
Ionis Pharmaceuticals, Inc.: Top Legal Advisors
Ionis Pharmaceuticals, Inc.: Top Financial Advisors
Ionis Pharmaceuticals, Inc.: Capital Raising
Ionis Pharmaceuticals, Inc.: Partnership
Ionis Pharmaceuticals, Inc.: Divestments
Ionis Pharmaceuticals, Inc.: Recent Developments
Ionis Pharmaceuticals, Inc.: News and Events Summary
Ionis Pharmaceuticals, Inc.: Corporate Governance
Ionis Pharmaceuticals, Inc.: Corporate Social Responsibility
Ionis Pharmaceuticals, Inc.: Financial Performance
Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Ionis Pharmaceuticals, Inc.: Research & Development
Ionis Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Ionis Pharmaceuticals, Inc.: Key Facts
Table 2: Ionis Pharmaceuticals, Inc.: Key Employees
Table 3: Ionis Pharmaceuticals, Inc.: Locations and Subsidiaries
Table 4: Ionis Pharmaceuticals, Inc.: Key Competitors
Table 5: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Table 7: Ionis Pharmaceuticals, Inc.: Targets and Partners
Table 8: Ionis Pharmaceuticals, Inc.: Top Deals 2022 - 2026YTD*
Table 9: Ionis Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Ionis Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Table 12: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Table 13: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Table 14: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Table 15: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)
Table 16: Ionis Pharmaceuticals, Inc.: News and Events Summary
Table 17: Ionis Pharmaceuticals, Inc.: Corporate Governance
Table 18: Ionis Pharmaceuticals, Inc.: Corporate Social Responsibility
Table 19: Ionis Pharmaceuticals, Inc.: Financial Performance
Table 20: Ionis Pharmaceuticals, Inc.: Regulatory and Legal Events
Table 21: Ionis Pharmaceuticals, Inc.: Research & Development
Table 22: Ionis Pharmaceuticals, Inc.: Strategy and Operations

List Of Figures

LIST OF FIGURES

Figure 1: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Ionis Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2022 - YTD*2026)
Figure 3: Ionis Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2022 - YTD*2026)
Figure 4: Ionis Pharmaceuticals, Inc.: Capital Raising by Deal Type (2022 - YTD*2026)
Figure 5: Ionis Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2022 - YTD*2026)
Figure 6: Ionis Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2022 - YTD*2026)
Figure 7: Ionis Pharmaceuticals, Inc.: Divestments Volume and Value Trend (2022 - YTD*2026)